description
PTK6 (BRK) is an oncogenic non-receptor tyrosine kinase that functions downstream of ERBB2 (HER2) (Xiang et al. 2008, Peng et al. 2015) and other receptor tyrosine kinases, such as EGFR (Kamalati et al. 1996) and MET (Castro and Lange 2010). Since ERBB2 forms heterodimers with EGFR and since MET can heterodimerize with bothe ERBB2 and EGFR (Tanizaki et al. 2011), it is not clear if MET and EGFR activate PTK6 directly or act through ERBB2. Levels of PTK6 increase under hypoxic conditions (Regan Anderson et al. 2013, Pires et al. 2014). The kinase activity of PTK6 is negatively regulated by PTPN1 phosphatase (Fan et al. 2013) and SRMS kinase (Fan et al. 2015), as well as the STAT3 target SOCS3 (Gao et al. 2012).PTK6 activates STAT3-mediated transcription (Ikeda et al. 2009, Ikeda et al. 2010) and may also activate STAT5-mediated transcription (Ikeda et al. 2011). PTK6 promotes cell motility and migration by regulating the activity of RHO GTPases RAC1 (Chen et al. 2004) and RHOA (Shen et al. 2008), and possibly by affecting motility-related kinesins (Lukong and Richard 2008). PTK6 crosstalks with AKT1 (Zhang et al. 2005, Zheng et al. 2010) and RAS signaling cascades (Shen et al. 2008, Ono et al. 2014) and may be involved in MAPK7 (ERK5) activation (Ostrander et al. 2007, Zheng et al. 2012). PTK6 enhances EGFR signaling by inhibiting EGFR down-regulation (Kang et al. 2010, Li et al. 2012, Kang and Lee 2013). PTK6 may also enhance signaling by IGF1R (Fan et al. 2013) and ERBB3 (Kamalati et al. 2000).PTK6 promotes cell cycle progression by phosphorylating and inactivating CDK inhibitor CDKN1B (p27) (Patel et al. 2015).PTK6 activity is upregulated in osteopontin (OPN or SPP1)-mediated signaling, leading to increased VEGF expression via PTK6/NF-kappaB/ATF4 signaling path. PTK6 may therefore play a role in VEGF-dependent tumor angiogenesis (Chakraborty et al. 2008).PTK6 binds and phosphorylates several nuclear RNA-binding proteins, including SAM68 family members (KHDRSB1, KHDRSB2 and KHDRSB3) (Derry et al. 2000, Haegebarth et al. 2004, Lukong et al. 2005) and SFPQ (PSF) (Lukong et al. 2009). The biological role of PTK6 in RNA processing is not known.For a review of PTK6 function, please refer to Goel and Lukong 2015

external resources
NCBI:1383025
REACTOME:R-HSA-8848021
PUBMED:15539407
PUBMED:15572663
PUBMED:25999240
PUBMED:20929863
PUBMED:23352614
PUBMED:20554524
PUBMED:23814047
PUBMED:21205088
PUBMED:18172307
PUBMED:25897081
PUBMED:18829532
PUBMED:24788754
PUBMED:25019382
PUBMED:8940083
PUBMED:19393627
PUBMED:18719096
PUBMED:22547065
PUBMED:21847121
PUBMED:19439179
PUBMED:22231447
PUBMED:25733683
PUBMED:20606012
PUBMED:18077133
PUBMED:15471878
PUBMED:20687930
PUBMED:23928995
PUBMED:16179349
PUBMED:26247733
PUBMED:11114724
PUBMED:17483331
PUBMED:22084245
PUBMED:10913193

genes
AKT1 , RHOA , CCND1 , BTC , CBL , CCNE1 , CDK2 , CDK4 , CDKN1B , CRK , DOCK1 , DOK1 , HBEGF , EGF , EGFR , EPAS1 , ERBB2 , ERBB3 , ERBB4 , EREG , NR3C1 , ARHGAP35 , NRG1 , HIF1A , HRAS , KRAS , NF1 , NRAS , PTK6 , PTPN1 , PXN , RAC1 , RASA1 , RASA2 , RPS27A , SFPQ , SRMS , STAT3 , UBA52 , UBB , UBC , RASAL1 , SYNGAP1 , SOCS3 , RASAL2 , NRG2 , BCAR1 , ELMO1 , RASA4 , GPNMB , KHDRBS3 , KHDRBS1 , NRG3 , RASA3 , PELP1 , STAP2 , ELMO2 , RASAL3 , ARAP1 , LRRK2 , NRG4 , DAB2IP , SPRED1 , SPRED2 , KHDRBS2 , SPRED3 , MIR5004 ,